MARKET

VKTX

VKTX

Viking Therapeutics Inc
NASDAQ
29.26
-1.22
-4.00%
Pre Market: 29.55 +0.29 +0.99% 07:21 02/19 EST
OPEN
30.53
PREV CLOSE
30.48
HIGH
30.70
LOW
29.25
VOLUME
1.43K
TURNOVER
0
52 WEEK HIGH
99.41
52 WEEK LOW
28.64
MARKET CAP
3.26B
P/E (TTM)
-29.0134
1D
5D
1M
3M
1Y
5Y
1D
BioMarin to Report Q4 Earnings: Here's What to Expect
NASDAQ · 2d ago
Weekly Report: what happened at VKTX last week (0210-0214)?
Weekly Report · 2d ago
H.C. Wainwright Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
TipRanks · 5d ago
Viking Therapeutics Becomes Oversold (VKTX)
NASDAQ · 5d ago
Add Up The Pieces: VBK Could Be Worth $335
NASDAQ · 5d ago
Target downgraded, Cisco upgraded: Wall Street’s top analyst calls
TipRanks · 5d ago
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga · 5d ago
LLY Rises More Than 4% in a Week: How to Play the Stock
NASDAQ · 5d ago
More
About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders, which is being evaluated in a Phase II b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. The Company is developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRb for X-linked adrenoleukodystrophy (X-ALD), a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells. It is also developing VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the treatment of various metabolic disorders.

Webull offers Viking Therapeutics Inc stock information, including NASDAQ: VKTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VKTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VKTX stock methods without spending real money on the virtual paper trading platform.